1586: Is the AIM ALL Share about to hit new lows?
1585: Stuart Gall of Intelligent Ultrasound Group: We are building an exciting business & anticipate reaching profitability on current cash
1584: Neil Herbert of Atlantic Lithium: Piedmont committing to Ewoyaa development funding moves us closer to production
1583: Should the Bank of England raise interest rates again in September?
1582: Alan Green on Frontier IP Group, Parkmead Group & CVS Group
1581: Where do you think the markets will be by the end of the year?
1580: Neil Herbert of Atlantic Lithium: MoU to assess the viability of feldspar production, could be significant
1579: Do you measure your investment performance?
1578: When should you sell a stock?
1577: Russ Mould on UK GDP, BoE and US CPI
1576: John Meyer on China Deflation, Atlantic Lithium, Aterian & Celsius Resources #CLA
1575: Does your portfoli have exposure to AI?
1574: Vadim Alexandre discusses Spectral MD, Lunglife AI & Destiny Pharma
1573: What % of your total portfolio value does your biggest investment take up?
1572: Jonathan Owen of Metals One: Highly conductive zones demonstrate potential for massive nickel-copper-cobalt sulphide mineralisation
1571: How many stocks should you hold?
1570: Vox Markets Fund Manager Series: Chris Mcvey of Octopus Investments
1569: Neil Herbert of Atlantic Lithium discusses the recent media speculation & their high-grade drilling results
1568: Q&A with Lunglife AI's CEO, Paul Pagano
1567: Alan Green on Warpaint London, Sovereign Metals & Ora Technology
1566: Time to get an EV?
1565: Richard Harpham of XP Factory: The size of the market still available to us is really significant
1564: Is now a good time to buy the house builders?
1563: Paul & Justin cover some news investments and updates of current ones
1562: Did the BoE do the right thing, for once!?
1561: Q&A with Saietta Exec Chairman, Tony Gott
1560: Stefan Bernstein of Greenroc: We have one of the highest-grade graphite deposits in the world at Amitsoq
1559: Alan Green covers Harland & Wolff, Tekcapital & Versarien
1558: John Meyer on lab grown diamonds, Bushveld Minerals, Power Metals Res & WH Ireland
1557: Olivier Mussat of ATOME Energy: We are playing in a $200bn market, which we can help decarbonise
1556: hVIVO’s Mo Khan: “We have now got 100% contracted work this year to hit our revenue targets”.
1555: Can you get excited about investing in big companies?
1554: hVIVO’s Mo Khan: “the industry is really waking up to the value of human challenge models”
1553: Q&A with Fadel Partners CEO, Tarek Fadel
1552: Alan Green talks about: Destiny Pharma, ECR, Acuity, First Class Metals & Truspine
1551: Greg Madison of Shield Therapeutics: “There is a very substantial market opportunity for Accrufer®”
1550: Francesco Gardin of QBT: This patent is a small example of how many industrial secrets & patents we have and can develop
1549: Can you make money in the UK markets? Plus the winners, losers, the most read & the most followed
1548: John Meyer on improved liquidity plus Cornish Metals, Beowulf, Rainbow Rare Earths, Solgold, Sovereign Metals & Savannah Res
1547: Average mortgage rates have fallen for the first time in months plus winners, losers & most followed
1546: Vox Markets Fund Manager Series: Josh Northrop of Whitman Asset Management
1545: Is the bottom of the market behind us?
1544: UK grocery inflation continues downward trajectory plus today's winners, losers, most read & most followed
1543: Richard Bennett of Getec: 3 recent contract wins represent significant addition to orderbook
1542: Oxford Cannabinoid's breakthrough oral immunotherapy: “The initial data demonstrates excellent potential”
1541: Alan Green talks about: Sovereign Metals, Smart Metering Systems, ECR Minerals & WINIT365
1540: UK Trade Deal, House Prices Fall plus today's winners, losers, the most read & the most followed
1539: Gatwick holiday strikes plus today's winners, losers, the most read & the most followed
1538: John Meyer on China's deflation plus Bushveld Minerals, Empire Metals & Strategic Minerals
1537: Vadim Alexandre discusses a big U.S. AI deal within biotech and suggests this is just the start
next page